Blind spots in the implementation of point-of-care diagnostics for underserved communities
Source abstract
Abstract
Point-of-care (POC) diagnostics are particularly important in resource-limited settings. However, to ensure their sustainability, deployment and uptake by underserved communities, systemic, infrastructural, operational and logistical limitations need to be addressed.
The source flagged this abstract for review. Check formulas and completeness against the original publication.
Source: openaire · Quality: needs review · Source record ↗
Source flags: short_text
Source flags: short_text
Research context
OpenAlex topics: Clinical Laboratory Practices and Quality Control · Genetics, Bioinformatics, and Biomedical Research · SARS-CoV-2 detection and testing
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (10)
Show source-provided references
1. Yadav, H., Shah, D., Sayed, S., Horton, S. & Schroeder, L. F. Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys. Lancet Global Health 9, e1553–e1560 (2021).10.1016/S2214-109X(21)00442-3 ↗
2. Maluleke, K., Musekiwa, A. & Mashamba-Thompson, T. Evaluating supply chain management of SARS-CoV-2 point-of-care (POC) diagnostic services in primary healthcare clinics in Mopani District, Limpopo Province, South Africa. PLoS ONE 18, e0287477 (2023).10.1371/journal.pone.0287477 ↗
3. Oyedijo, A., Adams, K. & Koukpaki, S. In Business in Africa in the Era of Digital Technology: Essays in Honour of Professor William Darley (Abugre, J. B. et al.) 121–140 (2021).10.1007/978-3-030-70538-1_8 ↗
4. Mashamba-Thompson, T. P. Diagnostics 12, 716 (2022).10.3390/diagnostics12030716 ↗
5. Atchison, C. et al. Usability and acceptability of home-based self-testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies for population surveillance. Clin. Infect. Dis. 72, e384–e393 (2021).10.1093/cid/ciaa1178 ↗
6. Conserve, D. F., Mathews, A., Choko, A. T. & Nelson, L. E. Preparing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) self-testing implementation: lessons learned from HIV self-testing. Front. Med. 7, 599521 (2020).10.3389/fmed.2020.599521 ↗
7. Drucker, E. & Krapfenbauer, K. Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. EPMA J. 4, 1–10 (2013).10.1186/1878-5085-4-7 ↗
8. Emery, J. R. Skin pigmentation as an influence on the accuracy of pulse oximetry. J. Perinatol. 7, 329–330 (1987).
9. Bodicoat, D. H. et al. Promoting inclusion in clinical trials — a rapid review of the literature and recommendations for action. Trials 22, 1–11 (2021).10.1186/s13063-021-05849-7 ↗
10. Bharadwaj, M., Bengtson, M., Golverdingen, M., Waling, L. & Dekker, C. Diagnosing point-of-care diagnostics for neglected tropical diseases. PLoS Negl. Trop. Dis. 15, e0009405 (2021).10.1371/journal.pntd.0009405 ↗